Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05842044 · ClinicalTrials.gov registry record · Phase 2
NSAID Use After Robotic Partial Nephrectomy
A Phase 2 study of Kidney Cancer and Renal Cancer, sponsored by University of Miami.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 110
- Enrollment target
- 1
- Study location
NCT05842044: Recruiting Phase 2 study of Kidney Cancer and Renal Cancer, sponsored by University of Miami.
NCT05842044 is a Phase 2 study of Kidney Cancer and Renal Cancer that is actively recruiting participants, run by University of Miami. The registered enrollment target is 110 participants, below the 879-participant average among 60 other Kidney Cancer trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05842044, a Phase 2 study of Kidney Cancer and Renal Cancer, is actively recruiting participants, sponsored by University of Miami.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 110 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to see how effective non-steroidal anti-inflammatory drugs (NSAIDs) are at controlling pain without side effects in participants after robotic-assisted partial nephrectomy.
Primary Outcome
Rate of opioid use is defined as the number of participants who used opioid medications during the post-operative period (defined as end of surgery to post-operative follow up visit) divided by total number of participants in the group at postoperative visit.
Conditions Studied
Interventions
- DRUG Acetaminophen
- DRUG Ketorolac
- DRUG Ibuprofen
- DRUG Oxycodone
- DRUG Hydromorphone
Study Locations (1)
Florida
- University of Miami - Miami
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2023-09-15 |
| Est. Completion | 2026-09-30 |
| Phase | Phase 2 |
What NCT05842044 shows while recruiting
NCT05842044 is an interventional study that assigns participants to a tested intervention. The registered 110 participants enrollment target is mid-sized for trials with a published cap, below the 879-participant average among 60 other Kidney Cancer trials with a reported enrollment target (87% lower).
The record links to 3 conditions, with Kidney Cancer appearing as the primary indexed condition, and to 5 interventions - of which Acetaminophen is the first listed.
NCT05842044 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT05842044 about?
NCT05842044 is a clinical study titled "NSAID Use After Robotic Partial Nephrectomy". The purpose of this study is to see how effective non-steroidal anti-inflammatory drugs (NSAIDs) are at controlling pain without side effects in participants after robotic-assisted partial nephrectomy.
What is the current status of trial NCT05842044?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 110 participants. The study started on 2023-09-15. Estimated completion is 2026-09-30.
What conditions does trial NCT05842044 study?
This clinical trial studies the following conditions: Kidney Cancer, Renal Cancer, Renal Neoplasm.
What interventions are being tested in trial NCT05842044?
The interventions under investigation include: Acetaminophen (DRUG), Ketorolac (DRUG), Ibuprofen (DRUG), Oxycodone (DRUG), Hydromorphone (DRUG).
Who is sponsoring clinical trial NCT05842044?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05842044 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Kidney Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05842044's enrollment target sits among peer trials
110 25th of 60 higher than 35 of 60 other Kidney Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Kidney Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Study of Olaparib in Metastatic Renal Cell Carcinoma Patients With DNA Repair Gene Mutations
RECRUITING · Phase 2
-
Neoadjuvant Pembrolizumab and Axitinib in Renal Cell Carcinoma With Inferior Vena Cava Tumor Thrombus
RECRUITING · Phase 2
-
Pre-NEOSHIFT-RCC: Neoadjuvant HIF-Inhibitor Immunotherapy in RCC
RECRUITING · Phase 2
-
CYTO Reductive Surgery in Kidney Cancer Plus Immunotherapy and Targeted Kinase Inhibition
RECRUITING · Phase 2
-
Study of Nivolumab in Combination With 177Lu-girentuximab for Kidney Cancer
ACTIVE NOT RECRUITING · Phase 2
-
A Trial of Belzutifan (PT2977, MK-6482) in Combination With Cabozantinib in Patients With Clear Cell Renal Cell Carcinoma (ccRCC) (MK-6482-003)
ACTIVE NOT RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01530373 · 110 participants · Phase 2
Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients
- NCT02379377 · 110 participants · Phase 1
18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or Transplant
- NCT02411773 · 110 participants · Phase 1
Sympatholysis in Chronic Kidney Disease
- NCT03190941 · 110 participants · Phase 1
Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI